Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
Iqrar Ahmad, Rahul Pawara, Sanjay J. Surana, et al.
Topics in Current Chemistry (2021) Vol. 379, Iss. 6
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry
Zilun Li, Meixiu Peng, Pin Chen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 424-440.e7
Open Access | Times Cited: 44
Host Cell Targets for Unconventional Antivirals against RNA Viruses
Vicky C. Roa-Linares, Manuela Escudero-Flórez, Miguel Vicente‐Manzanares, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 776-776
Open Access | Times Cited: 17
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Aijia Wu, Kunyu Shi, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115923-115923
Closed Access | Times Cited: 17
Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds
Jiani Lu, Yan Tang, Hongtao Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2243-2243
Open Access
Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study
Cecep Suhandi, Siti Sarah Alfathonah, Aliya Nur Hasanah
Molecules (2023) Vol. 28, Iss. 13, pp. 5187-5187
Open Access | Times Cited: 13
Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats
Esmail M. El‐Fakharany, Hamada El‐Gendi, Yousra A. El‐Maradny, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125552-125552
Open Access | Times Cited: 12
Molecular Analysis of SARS-CoV-2 Spike Protein-Induced Endothelial Cell Permeability and vWF Secretion
Yuexi Guo, Venkateswarlu Kanamarlapudi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5664-5664
Open Access | Times Cited: 10
Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction
Shahzaib Ahamad, Hashim Ali, Ilaria Secco, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
Characterization of passive microfluidic mixer with a three-dimensional zig-zag channel for cryo-EM sampling
Byungjin Lee, MinJoong Kim, Seoyeon Oh, et al.
Chemical Engineering Science (2023) Vol. 281, pp. 119161-119161
Closed Access | Times Cited: 9
Bioactive components of different nasal spray solutions may defeat SARS-Cov2: repurposing and in silico studies
Mohammad Faheem Khan, Waseem Ahmad Ansari, Tanveer Ahamad, et al.
Journal of Molecular Modeling (2022) Vol. 28, Iss. 8
Closed Access | Times Cited: 13
Exploring multifunctional components from Andrographis paniculata by affinity ultrafiltration with three molecular targets
Huixia Feng, Guilin Chen, Mingquan Guo
Food Chemistry (2022) Vol. 404, pp. 134515-134515
Closed Access | Times Cited: 13
A Peek into Pandora’s Box: COVID-19 and Neurodegeneration
Abhishek Chandra, Ashu Johri
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 190-190
Open Access | Times Cited: 11
Botanical inhibitors of SARS-CoV-2 viral entry: a phylogenetic perspective
Caitlin J. Risener, Sunmin Woo, Tharanga Samarakoon, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach
Abdul Manan, Rameez Hassan Pirzada, Muhammad Haseeb, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10716-10716
Open Access | Times Cited: 10
SARS-CoV-2 Enters Human Leydig Cells and Affects Testosterone Production In Vitro
Lu Li, Chantal M. Sottas, Hsu-Yu Chen, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1198-1198
Open Access | Times Cited: 5
Apelin as a new therapeutic target for COVID-19 treatment
Jihwan Park, Minhan Park, Yongsoo Kim, et al.
QJM (2022) Vol. 116, Iss. 3, pp. 197-204
Open Access | Times Cited: 9
Upregulation of key factors of viral entry of corona‐ and influenza viruses upon TLR3‐signaling in cells from the respiratory tract and clinical treatment options by 1,8‐Cineol
Leonie Hose, Matthias Schürmann, Holger Sudhoff
Phytotherapy Research (2024) Vol. 38, Iss. 9, pp. 4453-4466
Open Access | Times Cited: 1
Site-Specific Covalent Immobilization of SMA-Stabilized ACE2 for SARS-CoV-2 Recognition and Drug Screening
Shuai Ge, Chéng Wáng, Min Si, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 28, pp. 33348-33361
Closed Access | Times Cited: 4
MLN-4760 Induces Oxidative Stress without Blood Pressure and Behavioural Alterations in SHRs: Roles of Nfe2l2 Gene, Nitric Oxide and Hydrogen Sulfide
Michal Kluknavský, Andrea Mičurová, Martina Cebová, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2385-2385
Open Access | Times Cited: 7
Biphenyl furanocoumarin compounds inhibit SARS-CoV-2 spike pseudovirus infection by binding ACE2
Yuexin Lv, Shuai Ge, Qiumei Zhu, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 5, pp. 2651-2658
Closed Access | Times Cited: 2
Molecular Imaging of ACE2 Expression in Infectious Disease and Cancer
Zhiyao Li, A. Hasson, Lasya Daggumati, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1982-1982
Open Access | Times Cited: 2
Protein-Targeting Drug Discovery
Caterina Vicidomini, Giovanni N. Roviello
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1591-1591
Open Access | Times Cited: 2
Agonists or positive allosteric modulators of α7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells
Olena Kalashnyk, Olena Lykhmus, Raymond Sullivan, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 709, pp. 149825-149825
Closed Access
In-silico analysis of SARS-CoV-2 N protein host interactors involved in Parkinson’s Disease and Dementia
Priyanjal Jain, Urshila Naithani, Vijeta Prakash, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top